Nicholas M P King

8PUBLICATIONS
26CO-AUTHORS
Peripheral nervous systemCharacterisation of biological macromoleculesToxicology (incl. clinical toxicology)Quality assurance, chemometrics, traceability and metrological chemistryMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 24, 2026
Regulatory endorsement for the application of α-synuclein seed amplification assay as a susceptibility and risk biomarker for clinical trials targeting synucleinopathies.

|Jun 10, 2026
Characterization of Urinary Kidney Injury Biomarker Profiles in Healthy Japanese Subjects With Reference to a Counterpart US Study.

|Nov 24, 2025
Biomarkers of Drug-Induced Kidney Injury: Use in Clinical Trials and Recent Examples of Impact on Drug Development.

Tanja S Zabka, Michael Lawton, Tom Chu

|Aug 12, 2025
Special consideration: commentary on the 2025 FDA Bioanalytical Method Validation for Biomarkers.

Karen J Quadrini, Jiri Aubrecht, Nicholas M P King

|Jan 04, 2025
Urinary Kidney Injury Biomarker Profiles in Healthy Individuals and After Nephrotoxic and Ischemic Injury.

Sushrut S Waikar, Robin Mogg, Amanda F Baker

|Nov 06, 2024
Serum glutamate dehydrogenase activity enables sensitive and specific diagnosis of hepatocellular injury in humans.

Jiri Aubrecht, David Potter, John Michael Sauer

Pageof 2

Frequent Collaborators

3 joint publications

Jiri Aubrecht

3 joint publications

John-Michael Sauer

2 joint publications

Gary S Friedman

2 joint publications

Steven P Piccoli